{
    "pmcid": "10497418",
    "qa_pairs": {
        "How can the insights from AlphaFold-Multimer predictions be applied beyond nanobody design?": [
            "They can be used to develop small molecules or peptides that mimic inhibitory effects.",
            "They can be used to create vaccines targeting the SARS-CoV-2 spike protein.",
            "They can be used to engineer viral vectors for gene therapy.",
            "They can be used to enhance the immune response against unrelated pathogens."
        ],
        "How does AlphaFold-Multimer contribute to SARS-CoV-2 nanobody design according to the study?": [
            "By predicting interactions between nanobodies and the SARS-CoV-2 spike protein.",
            "By identifying mutations in the SARS-CoV-2 spike protein.",
            "By designing new nanobody sequences from scratch.",
            "By synthesizing nanobodies in vitro for testing."
        ],
        "What evolutionary concept is discussed in relation to MRN inhibition and viral-host interactions?": [
            "Convergent evolution and its role in conserved inhibition mechanisms.",
            "Divergent evolution leading to unique viral-host interaction pathways.",
            "Parallel evolution resulting in similar viral escape strategies.",
            "Adaptive radiation influencing viral mutation rates."
        ],
        "What role do molecular dynamics simulations play in the study's approach to nanobody development?": [
            "They validate the stability and efficacy of nanobody interactions with the spike protein.",
            "They predict the initial binding sites for nanobodies on the spike protein.",
            "They simulate the entire viral life cycle to identify intervention points.",
            "They optimize the production yield of nanobodies in laboratory settings."
        ],
        "What specific interaction does AlphaFold-Multimer predict that involves the iDDR domain of TRF2?": [
            "The interaction between the iDDR domain of TRF2 and the ATPase domain of Rad50.",
            "The interaction between the iDDR domain of TRF2 and the DNA-binding domain of MRN.",
            "The interaction between the iDDR domain of TRF2 and the helicase domain of CtIP.",
            "The interaction between the iDDR domain of TRF2 and the kinase domain of DNA-PK."
        ]
    }
}